Bio-equivalence Assessment

Bioequivalence Assessment studies are used to compare the expected in vivo biological equivalence of two formulations of a drug and this study is to assure therapeutic equivalence of generic products to innovator products. In the bioequivalence study, bioavailability should be compared for innovator and generic products. If this is not feasible, pharmacological effects supporting therapeutic efficacy or therapeutic effectiveness in major indications should be compared (These comparative tests are hereafter called pharmacodynamics studies and clinical studies, respectively). For oral products, dissolution tests should be performed, since they provide important information concerning bioequivalence.

Bioequivalence assessment includes strategies of topical dosage forms and bio equivalence approaches for transdermal dosage form and assessment of respiratory dosage form.

    Related Conference of Bio-equivalence Assessment

    November 09-10, 2020

    2nd World Congress on Drug Discovery and Drug Design

    Tokyo, Japan
    November 09-10, 2020

    21st Global Summit on Analytical and Bioanlaytical Techniques

    Amsterdam, Netherlands
    November 9-10, 2020

    Annual Meet on Pharmacovigilance & Drug Safety

    Tokyo, Japan
    November 09-10, 2020

    20th Medicinal & Pharmaceutical Sciences Congress

    Budapest, Hungary
    November 09-10 , 2020

    Asia Pacific Pharmaceutics & Drug Delivery Congress

    | Tokyo , Japan
    November 11-12, 2020

    4th World Congress on Eye and Vision

    Dubai, UAE
    November 16-17, 2020

    World Congress on Biologics and Biosimilars

    Kyoto, Japan
    November 23-24, 2020

    Pharmaceutics & Novel Drug Delivery Summit China

    Paris, France
    November 23-24, 2020

    21st Middle East PharmaTech & Expo

    Istanbul, Turkey
    November 25-26, 2020

    8th World Congress on Antibiotics, Antimicrobials & Antibiotic Resistance

    Singapore City, Singapore
    November 26-27, 2020

    11th World Congress on Bioavailability and Bioequivalence

    Istanbul, Turkey
    December 02-03, 2020

    2nd International Conference on Bio-Pharmaceuticals

    Auckland, Newzealand
    December 07-08, 2020

    International Liver Congress

    Dubai, UAE
    December 07-08, 2020

    International Conference on Biotechnology and Healthcare

    Auckland, Newzealand
    January 22-23, 2021

    1 st Global Summit on Generic Drugs and Quality Control

    Prague, Czech Republic
    January 22-23, 2021

    1 st World Congress on Rare Diseases & Orphan Drugs

    Prague, Czech Republic
    February 26-27, 2021

    2nd Annual Congress on Antibiotics and Bacterial Infections

    Geneva, Switzerland
    March 10-11, 2021

    6th Pharmaceutical Chemistry Conference

    Paris, France
    April 11-12, 2021

    2 nd World Pharma Expo

    Tokyo, Japan
    April 28-29, 2021

    31st Annual European Pharma Congress

    London, UK
    April 28-29, 2021

    14th European Biosimilars Congress

    London, UK
    May 17-18, 2021

    8th European Biopharma Congress

    Prague, Czech Republic
    May 19-20, 2021

    36th World Pharmacology and Therapeutics Forum

    Singapore, Singapore
    June 07-08, 2021

    2rd European Conference on Pharmacovigilance and Drug Safety

    Prague, Czech Republic
    July 10-11, 2021

    2 nd Pharma Expo China

    Tokyo, Japan
    August 16-17, 2021

    Global summit on Cosmetic & Reconstructive Surgery

    Tokyo, Japan
    August 16-17, 2021

    34rd World Congress on Pharmacology

    London, UK

    Bio-equivalence Assessment Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in